Foundation Medicine Announces Expanded Participation in National Cancer Institute's ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationO...
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
BOSTON, March 10, 2026 BUSINESS WIRE Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced its expanded participation with the National Cancer Institute (NCI) and ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) in the Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH). The initiative now includes the high-quality blood-based biomarker test, FoundationOne®Liquid CDx, to test new therapy combinations in select groups of adults and children with cancer. NCI is part of the National Institutes of Health. In 2023, Foundation Medicine began its participation in ComboMATCH through inclusion of its high-quality tissue-based biomarker test, FoundationOne®CDx. Foundation Medicine is a participating Designated Laboratory in the initiative, meaning that oncologists at ComboMATCH clinical sites may utilize their patients' prior commercial testing results from FoundationOne CDx and now, FoundationOne Liquid CDx, to h
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics [Yahoo! Finance]Yahoo! Finance
- Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]Yahoo! Finance
- FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Roche Falters In A Key Breast Cancer Readout [Seeking Alpha]Seeking Alpha
- Roche's Breast Cancer Drug Falls Short In Phase 3 Study [Yahoo! Finance]Yahoo! Finance